PROPRANOLOL HYDROCHLORIDE

PROPRANOLOL HYDROCHLORIDE was reported 72996 times

PROPRANOLOL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ULCERATED HAEMANGIOMA 50 0.8197
1 INFANTILE SPITTING UP 199 0.3805
2 NEOVASCULARISATION 64 0.2433
3 AMAUROSIS FUGAX 226 0.2098
4 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1174 0.1928
5 HAEMANGIOMA 348 0.1505
6 GRANULOMA SKIN 103 0.1255
7 PHONOPHOBIA 48 0.1043
8 REVERSIBLE AIRWAYS OBSTRUCTION 51 0.1004
9 CEREBRAL ARTERY THROMBOSIS 49 0.0953
10 BRAIN SCAN ABNORMAL 47 0.0842
11 THYROTOXIC CRISIS 90 0.0791
12 HYPOGLYCAEMIC SEIZURE 71 0.0782
13 BLOOD PARATHYROID HORMONE DECREASED 109 0.0735
14 ESSENTIAL TREMOR 81 0.0726
15 PHAEOCHROMOCYTOMA 47 0.0713
16 MEDICATION OVERUSE HEADACHE 57 0.0666
17 OESOPHAGEAL VARICES HAEMORRHAGE 113 0.0520
18 MASTOIDITIS 48 0.0489
19 URINARY TRACT DISORDER 219 0.0486
20 PRODUCT USED FOR UNKNOWN INDICATION 60 0.0477
21 PANNICULITIS 108 0.0446
22 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 60 0.0444
23 VARICES OESOPHAGEAL 134 0.0443
24 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 211 0.0411
25 RHEUMATOID NODULE 110 0.0399
26 DRUG TITRATION ERROR 101 0.0391
27 PULSELESS ELECTRICAL ACTIVITY 160 0.0383
28 HAEMORRHAGIC STROKE 280 0.0358
29 AREFLEXIA 93 0.0348
30 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 91 0.0342
31 HEPATORENAL SYNDROME 57 0.0337
32 AGORAPHOBIA 46 0.0336
33 NEOPLASM SKIN 50 0.0322
34 MIGRAINE WITH AURA 84 0.0309
35 SUSPECTED SUICIDE 143 0.0305
36 CARDIOGENIC SHOCK 436 0.0304
37 HEPATIC ENCEPHALOPATHY 277 0.0297
38 SEDATION 777 0.0296
39 SLEEP TERROR 121 0.0287
40 COMA SCALE ABNORMAL 83 0.0286
41 DRUG TOLERANCE DECREASED 80 0.0285
42 POISONING DELIBERATE 270 0.0285
43 SINUS BRADYCARDIA 268 0.0277
44 BRADYCARDIA 1463 0.0276
45 PERIPHERAL COLDNESS 378 0.0275
46 PRE-EXISTING CONDITION IMPROVED 169 0.0270
47 NIGHTMARE 929 0.0268
48 PARADOXICAL DRUG REACTION 97 0.0263
49 ALCOHOL INTERACTION 49 0.0252
50 PRODUCT ADMINISTRATION INTERRUPTED 196 0.0249
51 RHEUMATOID FACTOR POSITIVE 142 0.0246
52 DISTRIBUTIVE SHOCK 55 0.0243
53 BREATH SOUNDS ABNORMAL 119 0.0241
54 AKATHISIA 322 0.0236
55 ATRIOVENTRICULAR BLOCK FIRST DEGREE 101 0.0233
56 OCULAR DISCOMFORT 260 0.0231
57 SEROTONIN SYNDROME 443 0.0230
58 COMPLETED SUICIDE 1907 0.0229
59 SKIN NECROSIS 116 0.0223
60 HYPERTHYROIDISM 311 0.0215
61 HEAD DISCOMFORT 377 0.0213
62 CARDIO-RESPIRATORY ARREST 857 0.0205
63 PORTAL HYPERTENSION 62 0.0201
64 ANTIPSYCHOTIC DRUG LEVEL INCREASED 56 0.0199
65 GENERALISED OEDEMA 244 0.0197
66 ALTERED STATE OF CONSCIOUSNESS 412 0.0190
67 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1038 0.0189
68 PHOTOPHOBIA 355 0.0189
69 BRAIN INJURY 189 0.0188
70 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 135 0.0188
71 COMA 894 0.0188
72 SUICIDAL BEHAVIOUR 78 0.0187
73 BRUXISM 100 0.0185
74 AMMONIA INCREASED 94 0.0184
75 SELF-INJURIOUS IDEATION 77 0.0183
76 HALLUCINATIONS, MIXED 77 0.0183
77 ASCITES 537 0.0182
78 DISSOCIATION 139 0.0181
79 HYPERREFLEXIA 63 0.0181
80 HAEMATEMESIS 448 0.0177
81 VENTRICULAR ARRHYTHMIA 64 0.0175
82 SNORING 66 0.0174
83 PORTAL VEIN THROMBOSIS 56 0.0173
84 TEARFULNESS 74 0.0172
85 FOETAL GROWTH RESTRICTION 104 0.0171
86 RESPIRATORY RATE DECREASED 53 0.0169
87 INTENTIONAL OVERDOSE 1071 0.0167
88 OTITIS MEDIA 55 0.0166
89 MIGRAINE 1584 0.0166
90 HYPERACUSIS 61 0.0164
91 RESPIRATORY ACIDOSIS 64 0.0163
92 BRAIN DEATH 49 0.0158
93 TORSADE DE POINTES 124 0.0158
94 ANURIA 136 0.0158
95 ELECTROCARDIOGRAM QT PROLONGED 567 0.0157
96 HALLUCINATION, AUDITORY 250 0.0157
97 NEPHROLITHIASIS 715 0.0156
98 RED BLOOD CELL SEDIMENTATION RATE INCREASED 169 0.0153
99 ENURESIS 61 0.0151
100 OBSESSIVE-COMPULSIVE DISORDER 120 0.0149
101 BLOOD PRESSURE SYSTOLIC DECREASED 68 0.0149
102 COMMUNICATION DISORDER 57 0.0149
103 MULTIPLE DRUG OVERDOSE INTENTIONAL 47 0.0146
104 SWOLLEN TONGUE 456 0.0146
105 MULTIPLE DRUG OVERDOSE 72 0.0145
106 TOXICITY TO VARIOUS AGENTS 2441 0.0145
107 RESPIRATORY SYNCYTIAL VIRUS INFECTION 126 0.0145
108 HYPOMANIA 53 0.0144
109 DIPLOPIA 373 0.0143
110 POST-TRAUMATIC STRESS DISORDER 96 0.0143
111 HYPOGLYCAEMIA 692 0.0143
112 BUNDLE BRANCH BLOCK RIGHT 65 0.0141
113 DRUG LEVEL BELOW THERAPEUTIC 78 0.0141
114 ATRIOVENTRICULAR BLOCK 109 0.0141
115 PARKINSONISM 137 0.0140
116 PRODUCT USE ISSUE 2613 0.0139
117 MYDRIASIS 178 0.0139
118 SOMNAMBULISM 91 0.0139
119 DRUG INTOLERANCE 1334 0.0138
120 CONTRAINDICATED PRODUCT ADMINISTERED 417 0.0138
121 HYPERCALCAEMIA 170 0.0138
122 PRESYNCOPE 333 0.0137
123 SALIVARY HYPERSECRETION 137 0.0137
124 MUSCLE CONTRACTIONS INVOLUNTARY 48 0.0136
125 SHOCK 314 0.0136
126 HALLUCINATION, VISUAL 287 0.0136
127 MYOCLONUS 161 0.0135
128 GRANULOCYTOPENIA 76 0.0133
129 PANIC ATTACK 482 0.0132
130 TINNITUS 607 0.0132
131 CARDIAC ARREST 1086 0.0131
132 SLEEP APNOEA SYNDROME 250 0.0131
133 HEPATIC CIRRHOSIS 246 0.0131
134 LEFT VENTRICULAR HYPERTROPHY 56 0.0131
135 CIRCULATORY COLLAPSE 222 0.0130
136 HAEMODYNAMIC INSTABILITY 99 0.0130
137 PANIC DISORDER 50 0.0129
138 PRODUCT USE IN UNAPPROVED INDICATION 3193 0.0129
139 TRICUSPID VALVE INCOMPETENCE 101 0.0127
140 NEUROLEPTIC MALIGNANT SYNDROME 149 0.0126
141 VENTRICULAR TACHYCARDIA 207 0.0125
142 BLOOD LACTIC ACID INCREASED 66 0.0125
143 DRUG INTERACTION 1971 0.0124
144 SUICIDAL IDEATION 1132 0.0124
145 SLEEP DISORDER 872 0.0123
146 HYPERLIPIDAEMIA 147 0.0123
147 BIPOLAR DISORDER 132 0.0121
148 HYPOVOLAEMIC SHOCK 58 0.0121
149 GOITRE 49 0.0120
150 DIABETIC NEUROPATHY 59 0.0119
151 PANIC REACTION 86 0.0119
152 HEART RATE DECREASED 418 0.0119
153 TRISMUS 61 0.0118
154 MAJOR DEPRESSION 86 0.0118
155 PHARYNGEAL SWELLING 115 0.0117
156 HYPERHIDROSIS 1509 0.0117
157 AFFECTIVE DISORDER 92 0.0117
158 ULCER 186 0.0117
159 EAR INFECTION 311 0.0117
160 SCREAMING 74 0.0116
161 RESTLESS LEGS SYNDROME 210 0.0115
162 ENCEPHALOPATHY 283 0.0115
163 AORTIC VALVE INCOMPETENCE 49 0.0115
164 DYSPHEMIA 50 0.0114
165 TENSION HEADACHE 49 0.0114
166 SUPRAVENTRICULAR TACHYCARDIA 109 0.0114
167 POOR QUALITY SLEEP 245 0.0114
168 RESPIRATORY ARREST 313 0.0113
169 ARTERIOSCLEROSIS CORONARY ARTERY 75 0.0113
170 CONCUSSION 87 0.0112
171 ORTHOSTATIC HYPOTENSION 194 0.0111
172 INTERVERTEBRAL DISC DEGENERATION 103 0.0111
173 CYANOSIS 175 0.0111
174 RESPIRATORY DEPRESSION 136 0.0111
175 HYPOTHERMIA 112 0.0111
176 GENERALISED TONIC-CLONIC SEIZURE 183 0.0110
177 FACIAL PARALYSIS 94 0.0110
178 INITIAL INSOMNIA 113 0.0110
179 BLOOD THYROID STIMULATING HORMONE DECREASED 50 0.0110
180 DEPRESSED LEVEL OF CONSCIOUSNESS 434 0.0110
181 DELUSION 169 0.0109
182 DRUG TOLERANCE 55 0.0109
183 TREMOR 1802 0.0108
184 PSYCHOTIC DISORDER 319 0.0108
185 NEPHROGENIC ANAEMIA 50 0.0108
186 ALCOHOLISM 46 0.0107
187 PARANOIA 185 0.0107
188 BASAL CELL CARCINOMA 166 0.0106
189 SINUS TACHYCARDIA 151 0.0106
190 SUICIDE ATTEMPT 643 0.0106
191 MIDDLE INSOMNIA 197 0.0105
192 HYPOTONIA 105 0.0105
193 IMPAIRED GASTRIC EMPTYING 143 0.0105
194 APATHY 153 0.0105
195 MANIA 171 0.0104
196 TACHYCARDIA 919 0.0103
197 DRUG LEVEL INCREASED 171 0.0103
198 LOW BIRTH WEIGHT BABY 82 0.0103
199 HYPERKALAEMIA 358 0.0102
200 BRAIN FOG 160 0.0102
201 URINE ODOUR ABNORMAL 60 0.0102
202 DISTURBANCE IN ATTENTION 549 0.0102
203 DROOLING 70 0.0101
204 HEPATOCELLULAR CARCINOMA 77 0.0101
205 UNRESPONSIVE TO STIMULI 261 0.0101
206 METABOLIC ACIDOSIS 322 0.0101
207 HAEMATURIA 344 0.0100
208 SOMNOLENCE 2013 0.0100
209 RESTLESSNESS 364 0.0099
210 HYPOTENSION 1993 0.0099
211 INTENTIONAL SELF-INJURY 200 0.0099
212 AGRANULOCYTOSIS 184 0.0099
213 CARDIOTOXICITY 88 0.0099
214 THINKING ABNORMAL 182 0.0098
215 APNOEA 76 0.0098
216 PSYCHIATRIC SYMPTOM 72 0.0097
217 CARDIAC FLUTTER 63 0.0097
218 PULMONARY FIBROSIS 186 0.0097
219 BLOOD TRIGLYCERIDES INCREASED 171 0.0097
220 AGITATION 708 0.0096
221 VENTRICULAR FIBRILLATION 107 0.0096
222 IRRITABILITY 579 0.0096
223 WITHDRAWAL SYNDROME 403 0.0096
224 BLOOD THYROID STIMULATING HORMONE INCREASED 88 0.0096
225 SPINAL OSTEOARTHRITIS 84 0.0096
226 HALLUCINATION 716 0.0095
227 DYSARTHRIA 357 0.0095
228 METABOLIC DISORDER 55 0.0095
229 HYPERTHERMIA 72 0.0094
230 FEELING DRUNK 70 0.0094
231 ATRIOVENTRICULAR BLOCK COMPLETE 63 0.0094
232 FACIAL PAIN 84 0.0094
233 CATATONIA 49 0.0093
234 LETHARGY 534 0.0093
235 MATERNAL DRUGS AFFECTING FOETUS 71 0.0093
236 VENTRICULAR EXTRASYSTOLES 96 0.0092
237 BLEPHAROSPASM 58 0.0092
238 OFF LABEL USE 8062 0.0092
239 STREPTOCOCCAL INFECTION 51 0.0092
240 SOCIAL AVOIDANT BEHAVIOUR 53 0.0092
241 HEMIPLEGIA 76 0.0091
242 EYE PAIN 511 0.0090
243 EYE MOVEMENT DISORDER 62 0.0090
244 COLITIS ISCHAEMIC 61 0.0090
245 ANGIOEDEMA 399 0.0090
246 SKIN ULCER 233 0.0090
247 MITRAL VALVE INCOMPETENCE 102 0.0090
248 DRUG ERUPTION 159 0.0090
249 GASTROINTESTINAL MOTILITY DISORDER 48 0.0090
250 PHOTOSENSITIVITY REACTION 148 0.0090
251 DRUG TOXICITY 122 0.0089
252 EXTRAPYRAMIDAL DISORDER 222 0.0089
253 MYOPATHY 77 0.0089
254 SCOLIOSIS 55 0.0089
255 DIZZINESS POSTURAL 86 0.0089
256 INCOHERENT 57 0.0088
257 HEPATIC STEATOSIS 164 0.0088
258 HYPERVENTILATION 51 0.0088
259 DISORIENTATION 348 0.0088
260 SWELLING FACE 570 0.0087
261 PALPITATIONS 1019 0.0087
262 CARDIOMEGALY 107 0.0087
263 OBESITY 138 0.0087
264 INSOMNIA 2292 0.0086
265 VISUAL FIELD DEFECT 62 0.0086
266 MUSCLE RIGIDITY 102 0.0085
267 SYNCOPE 853 0.0085
268 APHASIA 257 0.0085
269 SYNOVITIS 153 0.0085
270 CHOLECYSTITIS ACUTE 48 0.0085
271 EXTRASYSTOLES 59 0.0084
272 FEELING OF BODY TEMPERATURE CHANGE 49 0.0084
273 HYPERTENSIVE CRISIS 93 0.0084
274 COGNITIVE DISORDER 389 0.0083
275 BODY TEMPERATURE DECREASED 82 0.0083
276 CARDIAC MURMUR 72 0.0083
277 CONFUSIONAL STATE 1343 0.0083
278 DYSTONIA 161 0.0083
279 EAR DISCOMFORT 85 0.0083
280 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 397 0.0083
281 CEREBRAL DISORDER 61 0.0082
282 SCHIZOPHRENIA 100 0.0082
283 PHOTOPSIA 52 0.0082
284 TARDIVE DYSKINESIA 232 0.0082
285 NEUROLOGICAL SYMPTOM 47 0.0082
286 BLINDNESS 335 0.0082
287 HYPERSOMNIA 235 0.0082
288 DYSGRAPHIA 54 0.0082
289 PERSONALITY CHANGE 76 0.0082
290 ANXIETY 2319 0.0081
291 DYSPHONIA 475 0.0081
292 POISONING 102 0.0081
293 HIATUS HERNIA 105 0.0081
294 SINUS HEADACHE 48 0.0081
295 HYPONATRAEMIA 454 0.0081
296 DIVERTICULUM 57 0.0080
297 HYPERBILIRUBINAEMIA 83 0.0080
298 BLOOD PRESSURE INCREASED 1224 0.0080
299 INSURANCE ISSUE 122 0.0080
300 BRADYPHRENIA 52 0.0080
301 PRESCRIBED UNDERDOSE 158 0.0079
302 CHOLECYSTITIS CHRONIC 53 0.0079
303 DEPRESSION 1801 0.0079
304 STATUS EPILEPTICUS 89 0.0079
305 SEXUAL DYSFUNCTION 92 0.0078
306 NEPHROPATHY TOXIC 88 0.0078
307 NOCTURIA 95 0.0078
308 CRYING 284 0.0078
309 DECREASED INTEREST 46 0.0078
310 ABNORMAL DREAMS 215 0.0078
311 DYSKINESIA 315 0.0077
312 ECONOMIC PROBLEM 117 0.0077
313 COLD SWEAT 136 0.0077
314 HAEMORRHOIDS 150 0.0077
315 JAUNDICE 206 0.0076
316 PSYCHOMOTOR HYPERACTIVITY 127 0.0076
317 ARTERIOSCLEROSIS 72 0.0076
318 RESPIRATORY DISTRESS 211 0.0076
319 FORMICATION 53 0.0076
320 ILLNESS 784 0.0076
321 GASTRITIS 200 0.0076
322 COORDINATION ABNORMAL 106 0.0076
323 ECCHYMOSIS 52 0.0076
324 IMPAIRED QUALITY OF LIFE 109 0.0076
325 GRAND MAL CONVULSION 70 0.0076
326 MYOCARDIAL ISCHAEMIA 86 0.0075
327 AGGRESSION 377 0.0075
328 FIBROMYALGIA 183 0.0075
329 MENTAL DISORDER 327 0.0075
330 HEPATITIS 192 0.0075
331 URINARY INCONTINENCE 222 0.0075
332 SEIZURE 864 0.0075
333 LEUKOCYTOSIS 135 0.0075
334 DERMATITIS BULLOUS 54 0.0075
335 SPLENOMEGALY 87 0.0074
336 HYPOTHYROIDISM 237 0.0074
337 ATAXIA 88 0.0074
338 HEPATIC FAILURE 223 0.0074
339 APPETITE DISORDER 49 0.0074
340 TENDERNESS 77 0.0074
341 AFFECT LABILITY 71 0.0074
342 MUSCLE TWITCHING 170 0.0074
343 NECK PAIN 412 0.0074
344 C-REACTIVE PROTEIN INCREASED 268 0.0074
345 MOTOR DYSFUNCTION 75 0.0074
346 SLUGGISHNESS 75 0.0073
347 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1325 0.0073
348 HEAVY MENSTRUAL BLEEDING 66 0.0073
349 HYPOMAGNESAEMIA 102 0.0073
350 AMNESIA 476 0.0073
351 IMPAIRED DRIVING ABILITY 83 0.0073
352 VITAMIN D DEFICIENCY 71 0.0073
353 DERMATITIS CONTACT 83 0.0073
354 MYOCARDITIS 83 0.0072
355 MENTAL STATUS CHANGES 201 0.0072
356 DENTAL CARIES 80 0.0072
357 OESOPHAGITIS 79 0.0072
358 HYPERTENSION 1530 0.0072
359 DRUG SCREEN POSITIVE 57 0.0072
360 JOINT DISLOCATION 76 0.0072
361 VERTIGO 438 0.0072
362 TEMPERATURE INTOLERANCE 74 0.0072
363 RENAL PAIN 76 0.0072
364 LEFT VENTRICULAR DYSFUNCTION 48 0.0072
365 PNEUMONIA ASPIRATION 179 0.0072
366 ROTATOR CUFF SYNDROME 92 0.0072
367 HYPOKALAEMIA 330 0.0071
368 HYPERCHOLESTEROLAEMIA 69 0.0071
369 GASTROENTERITIS VIRAL 129 0.0071
370 VISION BLURRED 980 0.0071
371 MENTAL IMPAIRMENT 173 0.0071
372 SEASONAL ALLERGY 101 0.0071
373 DEPRESSED MOOD 377 0.0071
374 MELAENA 156 0.0071
375 ABNORMAL BEHAVIOUR 280 0.0071
376 BLOOD ALBUMIN DECREASED 56 0.0071
377 ABDOMINAL PAIN 1639 0.0070
378 HYPOKINESIA 102 0.0070
379 LOSS OF CONSCIOUSNESS 899 0.0070
380 ELECTROCARDIOGRAM ABNORMAL 55 0.0070
381 ANGER 237 0.0070
382 ANAL INCONTINENCE 63 0.0070
383 BLOOD SODIUM DECREASED 132 0.0070
384 BEDRIDDEN 92 0.0070
385 CHOLELITHIASIS 229 0.0070
386 PREMATURE BABY 210 0.0070
387 TREATMENT FAILURE 577 0.0070
388 WRONG PRODUCT ADMINISTERED 47 0.0069
389 HEART RATE IRREGULAR 157 0.0069
390 GASTROOESOPHAGEAL REFLUX DISEASE 557 0.0069
391 INTERVERTEBRAL DISC PROTRUSION 151 0.0069
392 HYPOPHOSPHATAEMIA 51 0.0069
393 MULTI-ORGAN FAILURE 119 0.0069
394 FEAR 185 0.0069
395 DISEASE RECURRENCE 326 0.0068
396 PALLOR 185 0.0068
397 ACUTE KIDNEY INJURY 1040 0.0068
398 SENSORY DISTURBANCE 109 0.0068
399 OSTEOARTHRITIS 287 0.0068
400 HEART RATE INCREASED 670 0.0068
401 FALL 2249 0.0068
402 INCREASED TENDENCY TO BRUISE 62 0.0067
403 CHOLESTASIS 129 0.0067
404 HEPATOMEGALY 66 0.0067
405 DRY MOUTH 544 0.0067
406 NEURALGIA 162 0.0067
407 DUODENAL ULCER 47 0.0067
408 BALANCE DISORDER 574 0.0066
409 THYROID DISORDER 102 0.0066
410 HUNGER 92 0.0066
411 CHILLS 774 0.0066
412 DIZZINESS 3279 0.0066
413 DELIRIUM 228 0.0066
414 LIP SWELLING 218 0.0065
415 RENAL TUBULAR NECROSIS 64 0.0065
416 ATELECTASIS 63 0.0065
417 PRESCRIBED OVERDOSE 126 0.0065
418 CONDITION AGGRAVATED 1977 0.0065
419 GASTRIC ULCER 123 0.0065
420 BLOOD PRESSURE DECREASED 430 0.0065
421 ANHEDONIA 170 0.0065
422 SPEECH DISORDER 338 0.0064
423 MUSCULOSKELETAL DISCOMFORT 111 0.0064
424 HEADACHE 4040 0.0064
425 INCREASED APPETITE 123 0.0064
426 MALNUTRITION 72 0.0064
427 VITAMIN D DECREASED 55 0.0064
428 MOOD SWINGS 205 0.0064
429 SUDDEN DEATH 68 0.0064
430 UPPER GASTROINTESTINAL HAEMORRHAGE 108 0.0064
431 ARRHYTHMIA 304 0.0064
432 RETINAL DETACHMENT 59 0.0064
433 IRON DEFICIENCY ANAEMIA 59 0.0064
434 ERECTILE DYSFUNCTION 164 0.0064
435 TYPE 2 DIABETES MELLITUS 215 0.0064
436 MEMORY IMPAIRMENT 877 0.0064
437 MUSCULOSKELETAL STIFFNESS 559 0.0064
438 GINGIVAL BLEEDING 87 0.0064
439 LIGAMENT SPRAIN 63 0.0064
440 OVERDOSE 1373 0.0064
441 PARAESTHESIA 1001 0.0064
442 POLYURIA 52 0.0063
443 BURSITIS 77 0.0063
444 RENAL FAILURE ACUTE 269 0.0063
445 ISCHAEMIC STROKE 113 0.0063
446 CONVULSION 362 0.0063
447 HEAD INJURY 200 0.0063
448 EPILEPSY 193 0.0063
449 ALANINE AMINOTRANSFERASE INCREASED 387 0.0063
450 RIB FRACTURE 129 0.0063
451 MOOD ALTERED 171 0.0063
452 DECREASED APPETITE 1456 0.0063
453 BLOOD CHOLESTEROL INCREASED 292 0.0063
454 ABNORMAL FAECES 51 0.0062
455 NERVOUSNESS 324 0.0062
456 EATING DISORDER 132 0.0062
457 ORAL DISCOMFORT 86 0.0062
458 MYALGIA 1051 0.0062
459 GASTROINTESTINAL PAIN 68 0.0062
460 TROPONIN INCREASED 47 0.0062
461 MUSCLE TIGHTNESS 100 0.0062
462 CHRONIC KIDNEY DISEASE 469 0.0062
463 BLOOD IRON DECREASED 73 0.0061
464 GROIN PAIN 54 0.0061
465 BLOOD CREATINE PHOSPHOKINASE INCREASED 177 0.0061
466 NERVE INJURY 68 0.0061
467 PARAESTHESIA ORAL 88 0.0061
468 DIABETES MELLITUS 465 0.0061
469 ASPARTATE AMINOTRANSFERASE INCREASED 324 0.0061
470 HYPERGLYCAEMIA 222 0.0061
471 UPPER-AIRWAY COUGH SYNDROME 50 0.0061
472 HYPOPHAGIA 155 0.0061
473 INCONTINENCE 64 0.0060
474 ANOREXIA 78 0.0060
475 VOMITING 2842 0.0060
476 BLOOD PRESSURE ABNORMAL 120 0.0060
477 BRONCHOSPASM 86 0.0060
478 WRIST FRACTURE 72 0.0060
479 PANCREATITIS ACUTE 135 0.0060
480 DRY THROAT 61 0.0060
481 BLOOD BILIRUBIN INCREASED 162 0.0060
482 EYE HAEMORRHAGE 80 0.0060
483 TOOTH FRACTURE 66 0.0060
484 LIVE BIRTH 50 0.0060
485 MEDICATION ERROR 331 0.0059
486 SEPSIS 664 0.0059
487 MICTURITION URGENCY 68 0.0059
488 CHOLECYSTECTOMY 68 0.0059
489 RHABDOMYOLYSIS 248 0.0059
490 CARPAL TUNNEL SYNDROME 83 0.0059
491 RENAL CYST 47 0.0059
492 BLOOD MAGNESIUM DECREASED 51 0.0059
493 NAUSEA 4665 0.0059
494 BLOOD PRESSURE FLUCTUATION 141 0.0059
495 FLANK PAIN 55 0.0059
496 MIOSIS 47 0.0059
497 EJECTION FRACTION DECREASED 91 0.0058
498 BLOOD UREA INCREASED 98 0.0058
499 BLOOD ALKALINE PHOSPHATASE INCREASED 145 0.0058
500 THERAPEUTIC RESPONSE UNEXPECTED 261 0.0058
501 ANKLE FRACTURE 90 0.0058
502 IMPAIRED WORK ABILITY 124 0.0058
503 VITREOUS FLOATERS 57 0.0058
504 DRUG LEVEL DECREASED 59 0.0058
505 DEAFNESS 151 0.0058
506 EUPHORIC MOOD 59 0.0058
507 CHROMATURIA 130 0.0058
508 ASPIRATION 63 0.0057
509 ARTHRITIS 452 0.0057
510 URINARY RETENTION 191 0.0057
511 OEDEMA PERIPHERAL 696 0.0057
512 LIVER FUNCTION TEST ABNORMAL 165 0.0057
513 LOSS OF LIBIDO 51 0.0057
514 ASTHENIA 2123 0.0056
515 VIRAL INFECTION 187 0.0056
516 JOINT INJURY 120 0.0056
517 FEELING JITTERY 107 0.0056
518 MULTIPLE ORGAN DYSFUNCTION SYNDROME 159 0.0056
519 EYELID PTOSIS 57 0.0056
520 HEPATIC ENZYME INCREASED 382 0.0056
521 TOOTH ABSCESS 57 0.0056
522 RASH PRURITIC 303 0.0056
523 QUALITY OF LIFE DECREASED 75 0.0056
524 RESPIRATORY FAILURE 407 0.0056
525 TREATMENT NONCOMPLIANCE 304 0.0056
526 ACTIVITIES OF DAILY LIVING IMPAIRED 110 0.0055
527 PHARYNGITIS STREPTOCOCCAL 60 0.0055
528 HYSTERECTOMY 48 0.0055
529 INABILITY TO AFFORD MEDICATION 55 0.0055
530 PARALYSIS 79 0.0055
531 THROAT TIGHTNESS 149 0.0055
532 HAEMATOCRIT DECREASED 109 0.0055
533 FOOT FRACTURE 104 0.0055
534 CHEST PAIN 1016 0.0055
535 THIRST 98 0.0055
536 FEELING ABNORMAL 1312 0.0055
537 INTENTIONAL DOSE OMISSION 156 0.0055
538 OSTEOPENIA 83 0.0055
539 DECREASED ACTIVITY 59 0.0055
540 CHEST DISCOMFORT 560 0.0055
541 HEPATITIS C 66 0.0055
542 BODY TEMPERATURE INCREASED 111 0.0054
543 ADRENAL INSUFFICIENCY 66 0.0054
544 ACUTE RESPIRATORY DISTRESS SYNDROME 96 0.0054
545 ABNORMAL WEIGHT GAIN 67 0.0054
546 BLOOD POTASSIUM DECREASED 163 0.0054
547 WHEEZING 320 0.0054
548 TRANSIENT ISCHAEMIC ATTACK 182 0.0054
549 DERMATITIS 113 0.0054
550 IMMUNODEFICIENCY 80 0.0054
551 THERAPEUTIC PRODUCT EFFECT DECREASED 240 0.0054
552 INFUSION SITE PAIN 69 0.0053
553 PRODUCT PHYSICAL ISSUE 108 0.0053
554 PHARMACEUTICAL PRODUCT COMPLAINT 139 0.0053
555 ARTHROPATHY 297 0.0053
556 ELECTROLYTE IMBALANCE 62 0.0053
557 WEIGHT INCREASED 1193 0.0053
558 MUSCULAR WEAKNESS 605 0.0053
559 EMOTIONAL DISORDER 164 0.0053
560 FEELING COLD 148 0.0053
561 SCAR 91 0.0053
562 DYSPHAGIA 504 0.0053
563 CONSTIPATION 1158 0.0053
564 DYSURIA 195 0.0053
565 HYPOXIA 186 0.0053
566 COAGULOPATHY 88 0.0053
567 SPINAL DISORDER 50 0.0053
568 GASTROENTERITIS 77 0.0053
569 DYSSTASIA 154 0.0053
570 PETECHIAE 55 0.0053
571 CANDIDA INFECTION 89 0.0053
572 BONE DISORDER 96 0.0053
573 LIMB DISCOMFORT 163 0.0053
574 BURNING SENSATION 369 0.0053
575 EMPHYSEMA 53 0.0052
576 COUGH 1473 0.0052
577 LACTIC ACIDOSIS 170 0.0052
578 HYPERSENSITIVITY 974 0.0052
579 BACK INJURY 57 0.0052
580 FEELING HOT 321 0.0052
581 PULMONARY CONGESTION 69 0.0052
582 FOOT DEFORMITY 58 0.0052
583 IRRITABLE BOWEL SYNDROME 112 0.0052
584 DIARRHOEA 3358 0.0052
585 EAR PAIN 101 0.0052
586 ACCIDENTAL OVERDOSE 190 0.0052
587 NIGHT SWEATS 167 0.0052
588 CYSTITIS 165 0.0052
589 ANGINA PECTORIS 148 0.0052
590 DYSPEPSIA 506 0.0051
591 PULMONARY OEDEMA 230 0.0051
592 PHARYNGEAL OEDEMA 79 0.0051
593 THERAPEUTIC RESPONSE DECREASED 311 0.0051
594 FATIGUE 3993 0.0051
595 NASAL CONGESTION 300 0.0051
596 ABDOMINAL PAIN UPPER 1051 0.0051
597 DIABETES MELLITUS INADEQUATE CONTROL 90 0.0051
598 CONTUSION 489 0.0051
599 BLOOD CALCIUM DECREASED 57 0.0051
600 BREAST PAIN 54 0.0051
601 SURGERY 296 0.0050
602 ABDOMINAL DISTENSION 527 0.0050
603 ACUTE RESPIRATORY FAILURE 97 0.0050
604 INFLAMMATION 260 0.0050
605 PANCREATITIS 266 0.0050
606 AUTOIMMUNE DISORDER 49 0.0050
607 TOOTHACHE 91 0.0050
608 HEMIPARESIS 85 0.0050
609 MUSCLE SPASMS 920 0.0050
610 INFUSION RELATED REACTION 332 0.0050
611 TOOTH INFECTION 66 0.0050
612 OXYGEN SATURATION DECREASED 281 0.0050
613 GAIT DISTURBANCE 957 0.0050
614 GAIT INABILITY 167 0.0050
615 URINARY TRACT INFECTION 851 0.0050
616 HYPOAESTHESIA 745 0.0050
617 RETCHING 106 0.0050
618 SKIN LACERATION 54 0.0050
619 AMENORRHOEA 87 0.0050
620 SINUS CONGESTION 67 0.0050
621 PAIN IN JAW 140 0.0049
622 FAECES DISCOLOURED 107 0.0049
623 UPPER RESPIRATORY TRACT INFECTION 228 0.0049
624 FEEDING DISORDER 100 0.0049
625 BLOOD PRESSURE SYSTOLIC INCREASED 96 0.0049
626 GAMMA-GLUTAMYLTRANSFERASE INCREASED 109 0.0049
627 RENAL INJURY 146 0.0049
628 TUBULOINTERSTITIAL NEPHRITIS 92 0.0049
629 CLOSTRIDIUM DIFFICILE COLITIS 52 0.0049
630 CAESAREAN SECTION 57 0.0049
631 DEHYDRATION 652 0.0049
632 OSTEOPOROSIS 201 0.0049
633 BACK DISORDER 79 0.0049
634 ROAD TRAFFIC ACCIDENT 203 0.0048
635 INTENTIONAL PRODUCT MISUSE 424 0.0048
636 MOUTH ULCERATION 102 0.0048
637 BLADDER DISORDER 48 0.0048
638 CEREBRAL INFARCTION 118 0.0048
639 BRAIN OEDEMA 61 0.0048
640 DRY EYE 241 0.0048
641 DYSPNOEA 2722 0.0048
642 ANAPHYLACTIC REACTION 265 0.0048
643 HEPATOCELLULAR INJURY 68 0.0048
644 OEDEMA 260 0.0048
645 SMALL INTESTINAL OBSTRUCTION 59 0.0048
646 PNEUMOTHORAX 76 0.0048
647 SINUSITIS 491 0.0048
648 DISCOMFORT 292 0.0048
649 HEPATIC CYTOLYSIS 61 0.0048
650 GLAUCOMA 92 0.0048
651 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 49 0.0048
652 POLLAKIURIA 199 0.0048
653 DEEP VEIN THROMBOSIS 310 0.0048
654 END STAGE RENAL DISEASE 87 0.0048
655 ANAEMIA 906 0.0047
656 OROPHARYNGEAL PAIN 439 0.0047
657 SKIN DISCOLOURATION 217 0.0047
658 WEIGHT DECREASED 1317 0.0047
659 PREMATURE DELIVERY 75 0.0047
660 NEUTROPHIL COUNT INCREASED 48 0.0047
661 RENAL FAILURE 621 0.0047
662 BODY HEIGHT DECREASED 50 0.0047
663 INFLUENZA 521 0.0047
664 WHITE BLOOD CELL COUNT INCREASED 179 0.0047
665 RHINORRHOEA 300 0.0046
666 EOSINOPHILIA 81 0.0046
667 DIABETIC KETOACIDOSIS 111 0.0046
668 FLATULENCE 262 0.0046
669 THERAPY PARTIAL RESPONDER 72 0.0046
670 BRONCHITIS 341 0.0046
671 LIMB INJURY 125 0.0046
672 DISABILITY 91 0.0046
673 ORAL PAIN 103 0.0046
674 INJURY 323 0.0046
675 GALLBLADDER DISORDER 82 0.0046
676 MUSCLE ATROPHY 58 0.0046
677 PULMONARY EMBOLISM 435 0.0046
678 CHOKING 89 0.0046
679 MALAISE 1998 0.0046
680 STAPHYLOCOCCAL INFECTION 150 0.0045
681 ABASIA 112 0.0045
682 PYREXIA 1568 0.0045
683 GASTRIC HAEMORRHAGE 52 0.0045
684 GASTROINTESTINAL DISORDER 403 0.0045
685 PERIPHERAL SWELLING 693 0.0045
686 WEIGHT FLUCTUATION 47 0.0045
687 RED BLOOD CELL COUNT DECREASED 128 0.0045
688 ARTHRALGIA 1860 0.0045
689 CARDIOMYOPATHY 66 0.0045
690 DRUG EFFECT LESS THAN EXPECTED 66 0.0044
691 EPISTAXIS 333 0.0044
692 FLUID RETENTION 226 0.0044
693 ABDOMINAL DISCOMFORT 745 0.0044
694 BLOOD URINE PRESENT 84 0.0044
695 JOINT STIFFNESS 116 0.0044
696 TACHYPNOEA 60 0.0044
697 HOT FLUSH 332 0.0044
698 MUSCULOSKELETAL CHEST PAIN 68 0.0044
699 SINUS DISORDER 87 0.0044
700 WOUND INFECTION 48 0.0044
701 HEREDITARY ANGIOEDEMA 47 0.0044
702 HYPOAESTHESIA ORAL 66 0.0044
703 LOWER LIMB FRACTURE 84 0.0044
704 DRUG INEFFECTIVE 5738 0.0043
705 BACK PAIN 1009 0.0043
706 FOETAL EXPOSURE DURING PREGNANCY 353 0.0043
707 PRODUCT SUBSTITUTION ISSUE 250 0.0043
708 SKIN LESION 119 0.0043
709 DISSEMINATED INTRAVASCULAR COAGULATION 61 0.0043
710 ABSCESS 69 0.0043
711 BLOOD POTASSIUM INCREASED 70 0.0043
712 ANAPHYLACTIC SHOCK 111 0.0043
713 INTENTIONAL PRODUCT USE ISSUE 376 0.0043
714 THROMBOCYTOPENIA 479 0.0043
715 TOXIC EPIDERMAL NECROLYSIS 65 0.0043
716 FLUSHING 435 0.0043
717 UPPER LIMB FRACTURE 85 0.0043
718 HAIR TEXTURE ABNORMAL 57 0.0043
719 EYE SWELLING 158 0.0042
720 RESPIRATORY DISORDER 127 0.0042
721 HERNIA 82 0.0042
722 THROAT IRRITATION 190 0.0042
723 MUSCLE SPASTICITY 52 0.0042
724 KIDNEY INFECTION 83 0.0042
725 ATRIAL FIBRILLATION 411 0.0042
726 PLATELET COUNT INCREASED 55 0.0042
727 LEUKOPENIA 211 0.0042
728 NODULE 55 0.0042
729 FACE OEDEMA 71 0.0042
730 MOVEMENT DISORDER 135 0.0042
731 SCIATICA 67 0.0042
732 PRODUCT PRESCRIBING ERROR 100 0.0042
733 NERVOUS SYSTEM DISORDER 131 0.0042
734 DYSPNOEA EXERTIONAL 158 0.0042
735 JOINT SWELLING 506 0.0042
736 SKIN CANCER 90 0.0042
737 MASS 58 0.0041
738 THERAPY CESSATION 213 0.0041
739 SPINAL OPERATION 51 0.0041
740 TOOTH DISORDER 92 0.0041
741 BLOOD CREATININE INCREASED 270 0.0041
742 DERMATITIS ALLERGIC 52 0.0041
743 GENERAL PHYSICAL HEALTH DETERIORATION 477 0.0041
744 RECTAL HAEMORRHAGE 177 0.0041
745 DRUG WITHDRAWAL SYNDROME 361 0.0041
746 RESPIRATORY TRACT INFECTION 107 0.0041
747 APHONIA 57 0.0041
748 ERUCTATION 79 0.0041
749 COVID-19 715 0.0041
750 LOCAL SWELLING 71 0.0041
751 GLOMERULAR FILTRATION RATE DECREASED 50 0.0041
752 HYPOCALCAEMIA 77 0.0041
753 CELLULITIS 204 0.0040
754 UNEVALUABLE EVENT 306 0.0040
755 PHARYNGITIS 50 0.0040
756 PAIN 2470 0.0040
757 SWELLING 376 0.0040
758 MULTIPLE SCLEROSIS 192 0.0040
759 LACRIMATION INCREASED 121 0.0040
760 TRANSAMINASES INCREASED 89 0.0040
761 PNEUMONIA 1294 0.0040
762 PRURITUS 1532 0.0040
763 MATERNAL EXPOSURE DURING PREGNANCY 355 0.0040
764 FUNGAL INFECTION 132 0.0040
765 ABDOMINAL PAIN LOWER 100 0.0040
766 ACUTE HEPATIC FAILURE 54 0.0039
767 HAEMORRHAGE INTRACRANIAL 59 0.0039
768 THERAPY NON-RESPONDER 177 0.0039
769 PULMONARY HYPERTENSION 82 0.0039
770 PAIN IN EXTREMITY 1157 0.0039
771 ALOPECIA 771 0.0039
772 THERAPEUTIC RESPONSE SHORTENED 130 0.0039
773 PANCYTOPENIA 219 0.0039
774 SUBDURAL HAEMATOMA 56 0.0039
775 LYMPHOCYTE COUNT DECREASED 69 0.0039
776 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 276 0.0039
777 VISUAL IMPAIRMENT 479 0.0039
778 INFLUENZA LIKE ILLNESS 317 0.0038
779 SOPOR 51 0.0038
780 NASOPHARYNGITIS 708 0.0038
781 HAEMATOMA 99 0.0038
782 ASTHMA 431 0.0038
783 BLISTER 214 0.0038
784 DYSGEUSIA 282 0.0038
785 LYMPHADENOPATHY 134 0.0038
786 PRODUCT PRESCRIBING ISSUE 82 0.0038
787 LIVER INJURY 92 0.0037
788 PRODUCT USE COMPLAINT 59 0.0037
789 DRUG ABUSE 311 0.0037
790 HAEMOGLOBIN DECREASED 382 0.0037
791 CORONARY ARTERY OCCLUSION 51 0.0037
792 DIVERTICULITIS 103 0.0037
793 CATARACT 220 0.0037
794 BONE PAIN 216 0.0037
795 RASH MACULO-PAPULAR 82 0.0037
796 CEREBROVASCULAR ACCIDENT 624 0.0037
797 HEPATOTOXICITY 82 0.0037
798 DRUG EXPOSURE DURING PREGNANCY 124 0.0036
799 POST PROCEDURAL COMPLICATION 70 0.0036
800 ORAL CANDIDIASIS 48 0.0036
801 ADVERSE DRUG REACTION 327 0.0036
802 SEPTIC SHOCK 158 0.0036
803 EXPOSURE DURING PREGNANCY 225 0.0036
804 LIVER DISORDER 160 0.0036
805 RASH MACULAR 126 0.0036
806 RESPIRATORY TRACT CONGESTION 57 0.0036
807 COLITIS 136 0.0036
808 INTENTIONAL DRUG MISUSE 75 0.0036
809 HAEMOPTYSIS 100 0.0036
810 GASTROINTESTINAL HAEMORRHAGE 299 0.0036
811 PROTEINURIA 68 0.0036
812 HAEMATOCHEZIA 197 0.0036
813 SNEEZING 80 0.0036
814 GOUT 64 0.0036
815 TENDONITIS 55 0.0035
816 DRUG RESISTANCE 91 0.0035
817 OSTEOMYELITIS 64 0.0035
818 CORONARY ARTERY DISEASE 107 0.0035
819 GLOSSODYNIA 79 0.0035
820 EYE DISORDER 116 0.0035
821 PRODUCT DOSE OMISSION ISSUE 1036 0.0035
822 MULTIPLE SCLEROSIS RELAPSE 241 0.0035
823 PRODUCT AVAILABILITY ISSUE 80 0.0035
824 PRODUCT ADMINISTRATION ERROR 71 0.0035
825 THERAPY INTERRUPTED 251 0.0035
826 PERICARDIAL EFFUSION 81 0.0035
827 PSORIATIC ARTHROPATHY 142 0.0035
828 PRODUCT TASTE ABNORMAL 47 0.0035
829 PRURITUS GENERALISED 75 0.0035
830 MUSCULOSKELETAL PAIN 181 0.0035
831 RENAL IMPAIRMENT 290 0.0034
832 CONJUNCTIVITIS 64 0.0034
833 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 180 0.0034
834 INTESTINAL OBSTRUCTION 130 0.0034
835 CARDIAC FAILURE CONGESTIVE 275 0.0034
836 HIP FRACTURE 110 0.0034
837 VISUAL ACUITY REDUCED 113 0.0034
838 TASTE DISORDER 69 0.0034
839 LYMPHOPENIA 48 0.0034
840 CLOSTRIDIUM DIFFICILE INFECTION 74 0.0034
841 SKIN DISORDER 112 0.0034
842 EYE PRURITUS 112 0.0033
843 RASH ERYTHEMATOUS 159 0.0033
844 HYPOACUSIS 143 0.0033
845 RASH GENERALISED 86 0.0033
846 MOBILITY DECREASED 238 0.0033
847 RASH 1439 0.0033
848 ERYTHEMA 678 0.0033
849 URTICARIA 551 0.0033
850 PRODUCTIVE COUGH 157 0.0033
851 AGEUSIA 82 0.0033
852 BLOOD LACTATE DEHYDROGENASE INCREASED 52 0.0033
853 RHEUMATOID ARTHRITIS 372 0.0033
854 INTERNATIONAL NORMALISED RATIO INCREASED 93 0.0033
855 SKIN HAEMORRHAGE 48 0.0032
856 STEVENS-JOHNSON SYNDROME 72 0.0032
857 PLATELET COUNT DECREASED 345 0.0032
858 FREQUENT BOWEL MOVEMENTS 87 0.0032
859 CARDIAC FAILURE 256 0.0032
860 OCULAR HYPERAEMIA 151 0.0032
861 ANOSMIA 46 0.0032
862 NEUROPATHY PERIPHERAL 302 0.0032
863 FRACTURE 60 0.0032
864 HEPATIC FUNCTION ABNORMAL 118 0.0032
865 PLEURAL EFFUSION 192 0.0032
866 MUSCULOSKELETAL DISORDER 60 0.0031
867 NEUTROPENIA 425 0.0031
868 GASTRIC DISORDER 107 0.0031
869 PSORIASIS 403 0.0031
870 DRUG DISPENSING ERROR 47 0.0031
871 EMOTIONAL DISTRESS 372 0.0031
872 CEREBRAL HAEMORRHAGE 109 0.0030
873 WHITE BLOOD CELL COUNT DECREASED 330 0.0030
874 BLOOD GLUCOSE DECREASED 146 0.0030
875 KNEE ARTHROPLASTY 64 0.0030
876 LOCALISED INFECTION 73 0.0030
877 ACUTE MYOCARDIAL INFARCTION 89 0.0030
878 BACTERIAL INFECTION 56 0.0030
879 RENAL DISORDER 139 0.0030
880 ABORTION SPONTANEOUS 118 0.0029
881 DRUG-INDUCED LIVER INJURY 92 0.0029
882 THROMBOSIS 235 0.0029
883 ADVERSE EVENT 268 0.0029
884 WOUND 81 0.0029
885 PAIN OF SKIN 78 0.0029
886 TOOTH LOSS 60 0.0029
887 HAEMORRHAGE 302 0.0029
888 CYTOMEGALOVIRUS INFECTION 48 0.0029
889 ECZEMA 151 0.0029
890 NEEDLE ISSUE 84 0.0029
891 EYE IRRITATION 166 0.0029
892 DRUG ADMINISTRATION ERROR 88 0.0029
893 PRODUCT DOSE OMISSION IN ERROR 81 0.0029
894 GLYCOSYLATED HAEMOGLOBIN INCREASED 72 0.0028
895 INFECTION 408 0.0028
896 SKIN FISSURES 55 0.0028
897 PROCEDURAL PAIN 78 0.0028
898 RASH PAPULAR 63 0.0028
899 CARDIAC DISORDER 262 0.0028
900 LIVER FUNCTION TEST INCREASED 60 0.0028
901 METASTASES TO LIVER 49 0.0028
902 PRODUCT DOSE OMISSION 181 0.0028
903 IMPAIRED HEALING 91 0.0028
904 STOMATITIS 168 0.0028
905 SYSTEMIC LUPUS ERYTHEMATOSUS 98 0.0028
906 INJECTION SITE MASS 102 0.0028
907 DEMENTIA 77 0.0028
908 HOSPITALISATION 422 0.0027
909 LABORATORY TEST ABNORMAL 81 0.0027
910 SKIN EXFOLIATION 231 0.0027
911 MENORRHAGIA 53 0.0027
912 PREGNANCY 54 0.0027
913 INCORRECT PRODUCT ADMINISTRATION DURATION 58 0.0027
914 INCORRECT DRUG ADMINISTRATION DURATION 75 0.0027
915 SPINAL FRACTURE 53 0.0026
916 FEBRILE NEUTROPENIA 175 0.0026
917 HERPES ZOSTER 151 0.0026
918 DRUG EFFECT DECREASED 141 0.0026
919 PRODUCT DISPENSING ERROR 57 0.0026
920 INJECTION SITE HAEMORRHAGE 209 0.0026
921 FEMUR FRACTURE 81 0.0026
922 LUNG DISORDER 128 0.0026
923 EXTRA DOSE ADMINISTERED 105 0.0026
924 WRONG TECHNIQUE IN DRUG USAGE PROCESS 94 0.0026
925 MENSTRUATION IRREGULAR 69 0.0026
926 DRUG EFFECT INCOMPLETE 93 0.0026
927 ILL-DEFINED DISORDER 154 0.0025
928 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 180 0.0025
929 BLOOD GLUCOSE INCREASED 469 0.0025
930 CARDIOVASCULAR DISORDER 63 0.0025
931 FULL BLOOD COUNT DECREASED 50 0.0025
932 MYOCARDIAL INFARCTION 432 0.0025
933 PERITONITIS 51 0.0025
934 ORAL HERPES 47 0.0024
935 DRUG DOSE OMISSION 398 0.0024
936 LOWER RESPIRATORY TRACT INFECTION 109 0.0024
937 INJECTION SITE PRURITUS 159 0.0024
938 MUCOSAL INFLAMMATION 62 0.0024
939 APPLICATION SITE PRURITUS 53 0.0023
940 BREAST CANCER FEMALE 62 0.0023
941 VAGINAL HAEMORRHAGE 100 0.0023
942 OSTEONECROSIS OF JAW 57 0.0023
943 INJECTION SITE ERYTHEMA 284 0.0023
944 INJECTION SITE SWELLING 174 0.0023
945 BONE MARROW FAILURE 46 0.0023
946 COLITIS ULCERATIVE 101 0.0023
947 NEUTROPHIL COUNT DECREASED 92 0.0023
948 DRY SKIN 300 0.0022
949 INCORRECT DOSE ADMINISTERED 513 0.0022
950 INJECTION SITE PAIN 688 0.0022
951 APPLICATION SITE ERYTHEMA 58 0.0022
952 INJECTION SITE REACTION 152 0.0022
953 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 56 0.0022
954 INJECTION SITE BRUISING 173 0.0022
955 INJECTION SITE URTICARIA 53 0.0022
956 EXPIRED PRODUCT ADMINISTERED 71 0.0021
957 INJECTION SITE RASH 65 0.0021
958 OSTEONECROSIS 68 0.0021
959 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 413 0.0020
960 PRODUCT QUALITY ISSUE 276 0.0020
961 SKIN BURNING SENSATION 143 0.0020
962 EXPOSURE VIA SKIN CONTACT 51 0.0020
963 UNDERDOSE 143 0.0020
964 DERMATITIS ATOPIC 103 0.0020
965 ACNE 147 0.0019
966 PNEUMONITIS 51 0.0019
967 INTERSTITIAL LUNG DISEASE 87 0.0018
968 BONE DENSITY DECREASED 55 0.0018
969 DISEASE PROGRESSION 207 0.0017
970 DEVICE MALFUNCTION 122 0.0017
971 NEOPLASM MALIGNANT 109 0.0016
972 MALIGNANT NEOPLASM PROGRESSION 166 0.0016
973 DEVICE DISLOCATION 68 0.0016
974 GYNAECOMASTIA 48 0.0015
975 ACCIDENTAL EXPOSURE TO PRODUCT 157 0.0015
976 NEOPLASM PROGRESSION 52 0.0015
977 DEATH 1263 0.0015
978 PLASMA CELL MYELOMA 57 0.0015
979 DEVICE BREAKAGE 56 0.0014
980 DRUG DEPENDENCE 221 0.0014
981 PRODUCT ADHESION ISSUE 49 0.0014
982 DEVICE ISSUE 117 0.0013
983 SKIN IRRITATION 58 0.0013
984 BREAST CANCER 112 0.0012
985 DEVICE LEAKAGE 47 0.0011
986 NO ADVERSE EVENT 194 0.0011
987 DEPENDENCE 48 0.0009
988 PRODUCT STORAGE ERROR 75 0.0009
989 DEVICE DIFFICULT TO USE 53 0.0008
990 DRUG DOSE OMISSION BY DEVICE 62 0.0008
991 DEVICE EXPULSION 48 0.0007